Gynecologic Clinical Trials

155 recruitingLast updated: July 25, 2026

There are 155 actively recruiting gynecologic clinical trials across 35 countries. Studies span Not Applicable, Phase 2, Phase 1, Early Phase 1, Phase 4, Phase 3. Top locations include Toronto, Ontario, Canada, Shanghai, Shanghai Municipality, China, New York, New York, United States. Updated daily from ClinicalTrials.gov.


Gynecologic Trials at a Glance

155 actively recruiting trials for gynecologic are listed on ClinicalTrialsFinder across 6 cities in 35 countries. The largest study group is Not Applicable with 70 trials, with the heaviest enrollment activity in Toronto, Shanghai, and New York. Lead sponsors running gynecologic studies include Fondazione Policlinico Universitario Agostino Gemelli IRCCS, University Health Network, Toronto, and University of Utah.

Browse gynecologic trials by phase

Treatments under study

About Gynecologic Clinical Trials

Looking for clinical trials for Gynecologic? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gynecologic trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gynecologic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 155 trials

Recruiting

Data Collection Study of Pediatric and Adolescent Gynecology Conditions

Disorders of Sex Development (DSD)Pediatric and Adolescent Cancers of the Genital TractReproductive Endocrine Conditions in Puberty+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)11,000 enrolled1 locationNCT04717349
Recruiting
Not Applicable

The Florida ASCENT Study

Breast CancerColorectal, CancerProstate Cancer+11 more
University of Florida100 enrolled1 locationNCT07042243
Recruiting
Phase 2

A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer

Mesonephric Gynecologic Cancer
Memorial Sloan Kettering Cancer Center40 enrolled7 locationsNCT05787561
Recruiting
Not Applicable

Vaginal Dilator Therapy After Pelvic Radiation

vaginal stenosisGynecologic CancersUrologic Cancer+3 more
Duke University130 enrolled1 locationNCT07216456
Recruiting
Phase 1

Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors

Breast CancerGynecologic Cancers
Oregon State University60 enrolled3 locationsNCT07055854
Recruiting
Phase 2

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Breast CancerLiver CancerColorectal, Cancer+19 more
University of California, Irvine75 enrolled1 locationNCT06580002
Recruiting
Not Applicable

Cs-131LDR Brachytherapy for Organ-Preserving Irradiation for Recurrent Cervical and Endometrial Cancer

Gynecologic Cancer
Denise Fabian10 enrolled1 locationNCT07631572
Recruiting
Not Applicable

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Ovarian CancerMelanomaHead and Neck Cancer+5 more
Memorial Sloan Kettering Cancer Center324 enrolled7 locationsNCT05053230
Recruiting
Not Applicable

CARE Tool Study Aim 3

Colorectal, CancerProstate CancerLung Cancer+1 more
Washington University School of Medicine430 enrolled3 locationsNCT07296887
Recruiting
Phase 1Phase 2

A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)

Tumours, Gynecological
GlaxoSmithKline305 enrolled81 locationsNCT06796907
Recruiting

Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer

Primary Peritoneal CancerRecurrent Ovarian CancerRecurrent Fallopian Tube Cancer+5 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy500 enrolled1 locationNCT07667192
Recruiting
Not Applicable

Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment

Hereditary Cancer SyndromeGynecologic Cancer
Weill Medical College of Cornell University150 enrolled4 locationsNCT05562778
Recruiting
Not Applicable

BOLSTER: Learning New Skills to Thrive

Advanced CancerGynecologic CancerGastrointestinal Cancer
Dana-Farber Cancer Institute600 enrolled2 locationsNCT06936878
Recruiting
Not Applicable

Comparison of Self-Locking Versus Traditional Sutures in Double-Layer Laparoscopic Vaginal Vault Closure After Hysterectomy (BI-SURE Trial)

Gynecologic CancersPostoperative ComplicationsVaginal Cuff Dehiscence
Azienda Ospedaliero-Universitaria di Parma310 enrolled5 locationsNCT07313839
Recruiting
Not Applicable

Study Evaluating the Success Rate of Outpatient Management of the Total Benign Hysterectomy by Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) Compared to Each of the Two Laparoscopic Routes (Conventional and Robot-assisted).

SurgeryGynecologic Disease
Elsan132 enrolled1 locationNCT06471049
Recruiting

A Study of HARMONIC 700 Shears With Advanced Hemostasis in Pediatric and Adult Surgical Procedures

Pediatric Surgical ProceduresAdult Surgical ProceduresAdult Gynecological Procedures+2 more
Ethicon Endo-Surgery165 enrolled9 locationsNCT06608485
Recruiting
Phase 2

Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.

Gynecologic CancersEsophageal CancerGastrointestinal Cancers
John Waters50 enrolled1 locationNCT07039526
Recruiting

Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

Breast CancerColorectal, CancerLung Cancer+8 more
University Health Network, Toronto10,000 enrolled7 locationsNCT02906943
Recruiting
Not Applicable

Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2

Chemotherapy Induced Peripheral NeuropathyGynecologic Cancer
Duke University190 enrolled4 locationsNCT06139458
Recruiting
Not Applicable

Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors

Breast Cancer FemaleGynecologic Cancer
University of Utah19 enrolled1 locationNCT07120100